Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Return on Assets (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Return on Assets for 7 consecutive years, with 0.73% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 6.0% to 0.73% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.73% through Dec 2025, down 6.0% year-over-year, with the annual reading at 0.79% for FY2025, 5.0% down from the prior year.
  • Return on Assets hit 0.73% in Q4 2025 for BridgeBio Pharma, up from 0.75% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.51% in Q2 2021 to a low of 1.12% in Q4 2023.
  • Historically, Return on Assets has averaged 0.76% across 5 years, with a median of 0.74% in 2025.
  • Biggest five-year swings in Return on Assets: decreased -30bps in 2023 and later skyrocketed 49bps in 2024.
  • Year by year, Return on Assets stood at 0.69% in 2021, then decreased by -25bps to 0.87% in 2022, then decreased by -29bps to 1.12% in 2023, then skyrocketed by 40bps to 0.66% in 2024, then fell by -10bps to 0.73% in 2025.
  • Business Quant data shows Return on Assets for BBIO at 0.73% in Q4 2025, 0.75% in Q3 2025, and 0.77% in Q2 2025.